ESC Premium Access

Late outcomes of percutaneous coronary interventions (PCI) and subsequent life-quality in patients younger 40 years of age

Topic: Primary Percutaneous Coronary Intervention (PCI)

Presentation

About the speaker

Professor Fuad Abdullayev

Topchubashov Surgical Research Center, Baku (Azerbaijan)
0 follower

133 more presentations in this session

Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.

Speaker: Doctor M. Verdoia (Biella, IT)

Thumbnail

Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Thumbnail

Rapid pacing is an independent predictor for high implantation depth using self-expandable devices in TAVR

Speaker: Assistant Professor V. Veulemans (Duesseldorf, DE)

Thumbnail

Influence of the speed of deflation of the stent delivery system in the myocardial blush and st-segment resolution in primary angioplasty: a randomized study

Speaker: Doctor I. Lozano Martinez-Luengas (Gijon, ES)

Thumbnail

Biodegradable polymer drug eluting stents versus durable polymer drug eluting stents for percutaneous coronary intervention

Speaker: Doctor M. Kheifets (Petah Tikva, IL)

Thumbnail

Access the full session

Interventional Cardiology ePosters

Speakers: Professor F. Abdullayev, Doctor M. Verdoia, Associate Professor D. Maximkin, Assistant Professor V. Veulemans, Doctor I. Lozano Martinez-Luengas...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice - panel.

30 August 2021

Open Access

Management of ASCVD risk in patients with established ASCVD and on a population level.

30 August 2021

ESC Premium Access

Intracardiac mass revealed an unusual form of heart-disease in Europe.

27 August 2021

This platform is supported by

logo Novo Nordisk